Contact Us
Learn more
As your global CDMO partner we offer complete solutions in pharmaceutical manufacturing that adapt to your rapidly changing needs – from pre-clinical investigations and process development to flexible commercial cGMP production.
DCAT Week 2024
in New York City
FUJIFILM Diosynth Biotechnologies is delighted to be attending DCAT Week 2024, March 18th - 21st.
We look forward to this time to build relationships with our customers and partners. We're eagerly anticipating DCAT 2024, where industry pioneers will convene to delve into the latest trends and developments shaping our field. From networking events to interactive discussions, we're excited about the valuable connections and knowledge exchange that will unfold. Join us as we embark on this journey of discovery and innovation together!
Speak with us
Helping You Achieve Your Sustainability Goals
Service Offerings
Your End-to-End Provider to Support Your Medicine's Journey through the Regulatory Pathway and Product Life Cycle
Drug Substance
Drug Product
Finished Goods
Zero Emissions in Operations
Decarbonizing the Value Chain
Valued Partner for Customers
FUJIFILM Diosynth Biotechnologies is a leading provider of cell culture services for biologics, advancing and delivering life changing therapies. We offer complete solutions for cell line development, process development, late phase activities, clinical and commercial manufacturing of a wide variety of biopharmaceuticals.
As a CDMO Partner for Life™ our goal is to advance your cell therapies from lab to commercial scale leveraging our CGT expertise and global cGMP network. As a patient-driven organization delivering the highest quality cell therapy manufacturing solutions is our priority.
We are an established leader in advancing vaccines from preclinical development to commercial supply across multiple modalities. Partner with us to leverage our global expertise in development and optimization of cGMP scalable processes, the knowledge base of our global network of experts and leading edge technologies.
With over 30+ years’ of experience in microbial CDMO services, one of our core areas of expertise is the development of large-scale processes for recombinant protein expression in microbial hosts (E.coli, P.pastoris and S.cerevisiae).
Use this form to request a meeting.
